
News|Articles|March 13, 2024
Top 5 CROI 2024 Stories
Author(s)Contagion Editorial Team
This year at the Conference on Retroviruses and Opportunistic Infections (CROI), Lenacapavir shows virological suppression, Remdesivir reduces long covid risks, Bulevirtide benefits chronic HBV, HIV treatment enhances outcomes, vaginal ring or oral pre-exposure prophylaxis safe for HIV prevention throughout pregnancy.
Advertisement
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Listeria Outbreak Update: 27 Illnesses and 6 Deaths Linked to Packaged Meals
2
FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections
3
In A Matter of Months, MMR Vaccine Confidence Drops Significantly
4
Global Collaboration and Immune-Based Innovation Take Center Stage in AMR Development
5

































































































































































































































































































